Deconstructing the “types” of osteoarthritis

Abstract

The community acknowledges the staggering prevalence and disabling nature of osteoarthritis, and the crucial need for therapeutic advancement. In our quest to define a clinically meaningful endpoint and identify biomarkers that can serve as short-term treatment responses and reliable predictors of long-term outcomes, we must also strive to target therapies more effectively. This perspective article not only aims to elucidate the nomenclature of osteoarthritis types but also proposes a path towards greater transparency that has the potential to inspire a new era of both research and clinical practice.